American Century Companies’s Aratana Therapeutics, Inc. PETX Stock Holding History

American Century Companies’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-45,942	Closed	-$268K	–	1398
2018 Q3	$268K	Hold	45,942	–	–	﹤0.01%	1214
2018 Q2	$195K	Buy	+45,942	New	+$232K	﹤0.01%	1271
2017 Q2	–	Sell	-262,338	Closed	-$1.39M	–	1445
2017 Q1	$1.39M	Sell	262,338 -93,497	-26%	-$631K	﹤0.01%	1095
2016 Q4	$2.56M	Buy	355,835 +172,218	+94%	+$1.39M	﹤0.01%	995
2016 Q3	$1.72M	Buy	+183,617	New	+$1.52M	﹤0.01%	1086

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies's PETX Position: Q4 2018 in Review

American Century Companies sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2018, closing a stake of 45,942 shares — an estimated $268K sold.

American Century Companies first reported a position in PETX in Q3 2016 and held it in 5 quarters. The position peaked at $2.56M in Q4 2016. 115 funds tracked by Wall St. Rank hold PETX as of Q4 2018.

American Century Companies reported no remaining Aratana Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
American Century Companies sold 45,942 Aratana Therapeutics, Inc. shares in Q4 2018, an estimated $268K.
American Century Companies first reported a position in Aratana Therapeutics, Inc. in Q3 2016 and held it in 5 quarters.
American Century Companies's Aratana Therapeutics, Inc. position peaked at $2.56M in Q4 2016.
115 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2018.

Based on American Century Companies's 13F filing for Q4 2018, filed 13 Feb 2019.